Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

Fed Wants Weaker Markets, Investors Want a Bargain. Brace for Earnings Season.

Wall Street lowers fourth-quarter earnings expectations, AstraZeneca to buy CinCor Pharma in $1.8 billion deal, new Covid-19 strain is the…

AstraZeneca makes $1.8bn move for CinCor Pharma

The biotechnology giant said that it would spend around $1.3billion, or $26 per share, upfront taking over the Massachusetts-based business....…

AstraZeneca Neutral

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca auf "Neutral" mit einem Kursziel von 10100…

CinCor Pharma, Macys, Alibaba, and More Stock Market Movers

CinCor Pharma is being acquired by AstraZeneca in a deal valued at about $1.8 billion; Macy's issues a sales warning....…

TOP NEWS: AstraZeneca buys biotech CinCor for up to USD1.8 billion

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

CinCor stock soars 150% as AstraZeneca set to acquire it in up to $1.8B deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pharmabranche: AstraZeneca sichert sich mit Milliardendeal neuen Blutdrucksenker

Der Pharmakonzern kauft die US-Firma CinCor und sichert sich damit die weltweiten Rechte an dem Medikament Baxdrostat zur Blutdrucksenkung....…

FTSE 100 opens higher, AstraZeneca to pay up to US$1.8bn for ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca To Buy CinCor Pharma In Up To $1.8 Bln Deal

LONDON (dpa-AFX) - British drug major AstraZeneca Plc. (AZN.L, AZN) Monday said it has entered into a definitive agreement to…

AstraZeneca sichert sich mit Milliardendeal neuen Blutdrucksenker

Frankfurt (Reuters) - Der Pharmakonzern AstraZeneca will mit einem Milliardenzukauf in den USA sein Angebot an Herz- und Nierenmedikamenten ausbauen.…

AstraZeneca Returns to the M&A Trail: The London Rush

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astrazeneca erwirbt Cincor mit Herz-/Nieren-Medikament Baxdrostat

Von Joe Hoppe LONDON (Dow Jones)--Astrazeneca erwirbt das US-biopharmazeutische Unternehmen Cincor. Die Transaktion hat laut Mitteilung einen Wert bis…

BUSINESS LIVE: AZN buys US firm; Capricorn okays Palliser board picks

Among the companies with reports and trading updates today are AstraZeneca, Capricorn Energy, Vodafone, Boparan, Tortilla Mexican Grill and DeepVerge....…

UPDATE 1-AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 bln deal

...(Adds details) Jan 9 (Reuters) - AstraZeneca said on Monday......…

AstraZeneca PLC Will Buy CinCor for Cardiorenal Asset

AstraZeneca PLC Will Buy CinCor for Cardiorenal Asset...…

AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 billion deal

...(Reuters) - AstraZeneca said on Monday it will acquire U.S.-based......…

AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 bln deal

...Jan 9 (Reuters) - AstraZeneca said on Monday it will acquire U.S......…

CinCor Pharma to be Acquired by AstraZeneca

WALTHAM, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that it has…

AstraZeneca acquire CinCor for cardiorenal asset

9 January 2023 07:00 GMT AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline Acquisition to access global rights to baxdrostat, a novel…

LBT Innovations (ASX:LBT) partners with AstraZeneca for APAS Pharma development

LBT Innovations (LBT) has been engaged by AstraZeneca to undertake a full…...…

LBT Innovations to partner with AstraZeneca on development of APAS Pharma microbial monitoring product

This content is created by Smallcaps Authors. [Author : Imelda Cotton] Australian medical technology company LBT Innovations (ASX: LBT) will…

Omicron Subvariant XBB.1.5 Likely Resistant to AstraZeneca (AZN ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZenecas COVID drug Evusheld unlikely to neutralize newest variant, FDA says

The Food and Drug Administration late Friday said that AstraZeneca Plc's COVID-19 drug Evusheld may not provide protection against…

AstraZeneca Neutral

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Bank Credit Suisse hat das Kursziel für Astrazeneca von 11000 auf 11800 Pence angehoben,…

Friday’s Top Analyst Upgrades and Downgrades: American Express, AstraZeneca, Coinbase, Comcast, Delta Air Lines, Marathon Oil, Microsoft, Target and More

Fridays top analyst upgrades and downgrades included Ally Financial, American Express, AppLovin, AstraZeneca, Coinbase Global, Cognizant Technology Solutions, Comcast, CME,…

Brazil: return of pressure for vaccine brings back controversy about AstraZeneca in pregnant women

As soon as he took power, the inaugurated president, Lula da Silva (PT), and his health team made clear threats…

AstraZeneca: Ersteinschätzung

Toronto (www.aktiencheck.de) - Rating-Update: Etzer Darout, Analyst von BMO Capital Markets, startet die Coverage der Aktie von AstraZeneca plc (ISIN: GB0009895292,…

Zoom Appoints Cindy Hoots to Board of Directors

SAN JOSE, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Zoom Video Communications, Inc. (NASDAQ: ZM) announced that it…

AstraZeneca, Sanofi BLA for nirsevimab for respiratory syncytial virus accepted by FDA

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca started at outperform with $82 stock price target at BMO Capital

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi, AstraZeneca Respiratory Treatment Nirsevimab Biologics License Accepted by FDA

Sanofi, AstraZeneca Respiratory Treatment Nirsevimab Biologics License Accepted by FDA...…

Form 6-K ASTRAZENECA PLC For: Jan 03

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Total Voting Rights

3 January 2023 15:00 GMT Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca

GSK plc (NYSE: GSK) chief commercial officer Luke Miels says the company is looking at M&A targets that are under-appreciated worth…

Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer

DUBLIN, Dec. 30, 2022 /PRNewswire/ -- The "Bronchitis Treatments: Global Markets" report has been added to ResearchAndMarkets.coms offering. This study…

dpa-AFX ProFeed